IncFact
Company Profiles: Revenue, Growth, Competition

Gamida Cell Revenue, Growth & Competitor Profile

DBA MAZARS USA LLP
DBA WEISERMAZARS LLP
Last updated:

Company Awards

Fast Growing
Fastest Growing
Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Gamida Cell

Access the complete profile.

Gamida Cell Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
EmployeesOver 1,000Exact Company Size
Primary Industry541211 Offices of Certified Public Accountants
Additional NAICS Codes5417 Scientific Research & Development Services
Address116 Huntington Ave Fl 7
Boston, MA 02116

Note: Revenues for privately held companies are statistical evaluations.


Gamida Cell's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Gamida Cell is classified as operating in the Offices of Certified Public Accountants industry, NAICS Code 541211.

Gamida Cell Annual Revenue and Growth Rate

Gamida Cell Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $100 - $500 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Gamida Cell's revenues are gauged from an analysis of company filings.



Gamida Cell's Income Statement (based on Industry Averages)

Gamida Cell P&L$ Millions
Revenue (Sales) Gamida Cell Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Gamida Cell is developing and marketing. Gamida Cell doesn't have any recent trademark applications, indicating Gamida Cell is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
NICORD
Pharmaceutical preparations of stem cells derived from umbilical cord blood and expanded in culture for use in stem cell transplantation and regenerative therapy, in medical or clinical use
02/02/2021
INSPIRED TO CURE
Cell therapy pharmaceutical preparations; pharmaceutical preparations in the field of hematology, oncology, leukemia, and blood and bone marrow diseases and disorders
07/07/2020

See all trademarks and details in the Full Report.


Market Share of Gamida Cell's Largest Competitors

A competitive analysis shows these companies are in the same general field as Gamida Cell, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
ERNST & YOUNG INVESTMENT ADVISERSSecaucus, NJ100 
KPMG LLP C/O TOTAL REWARDS DEPTMontvale, NJ64 
PRICEWATERHOUSECOOPERSTampa, FL63 
DELOITTENew York, NY51 
ANALYSIS GROUPBoston, MA23 
BDO USAChicago, IL17 
CLIFTONLARSONALLENMinneapolis, MN15 
GRANT THORNTONChicago, IL12 
BEALES BESTVictoria, TX11 




Nearby Competitors

These companies are similar in business line and location to Gamida Cell. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ANALYSIS GROUPBoston, MA100 
CORPORATE FINANCE GROUPBoston, MA8 
GAMIDA CELLBoston, MA7 
ASPEN HR PEOBoston, MA4 
WOLF & COMPANY P.C.Boston, MA2 
O'CONNOR & DREW P.C.Braintree, MA1 




Future Competition: Gamida Cell's Fastest Growing Competitors

These companies are in the same general field as Gamida Cell and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Gamida Cell Competitors